ScholarIQanswers from OpenAlex

Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy

PaperCitations, authors & open-access status

Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy have?

ScholarIQcitation count

Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy has 128 citations in the OpenAlex counts ScholarIQ stores.

When was Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy published?

ScholarIQyear

Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy has 2020 year in the ScholarIQ index.

What is the open-access status of Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy?

ScholarIQoa status

Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy has gold oa status in the ScholarIQ index.

What is the DOI of Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy?

ScholarIQdoi

The DOI for Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy is on the source record.

What is the PMID of Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy?

ScholarIQpmid

The PMID for Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy is on the source record.

What is the OpenAlex record for Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy?

ScholarIQopenalex

The OpenAlex for Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial